Picture of Maven Income and Growth VCT 5 logo

MIG5 Maven Income and Growth VCT 5 News Story

0.000.00%
gb flag iconLast trade - 00:00
FinancialsConservativeSmall CapNeutral

REG - Maven Inc&Grwth 5 - Result of AGM

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260428:nRSb2561Ca&default-theme=true

RNS Number : 2561C  Maven Income and Growth VCT 5 PLC  28 April 2026

 

 

Maven Income and Growth VCT 5 PLC (the Company)

Result of Annual General Meeting

 

At the 2026 Annual General Meeting of the Company held at the offices of Maven
Capital Partners UK LLP, Kintyre House, 205 West George Street, Glasgow G2 2LW
on Tuesday, 28 April 2026 at 11.30am, all of the Resolutions put to the
Meeting were duly passed.

 

At the record date for the Annual General Meeting, being 24 April 2026, the
total number of voting rights in the Company stood at 267,364,248 and the
total number of shares in issue were 267,364,248. The Company advises that for
the Annual General Meeting, valid proxy appointments were made in respect of
11,768,958 shares and that the number of proxy votes lodged for each
Resolution were as follows:

 

     Resolutions                                                               For and Chairman's Discretion  Against  Withheld  Total
 1   To receive the Annual Report and audited Financial Statements             11,670,258                     17,275   81,425    11,768,958

 2   To approve the Directors' Remuneration Report                             10,715,075                     782,764  271,119   11,768,958

 3   To approve the Directors' Remuneration Policy                             10,698,540                     786,336  284,082   11,768,958

 4   To approve a final dividend                                               11,682,533                     5,000    81,425    11,768,958

 5   To re-elect Graham Miller as a Director                                   11,445,003                     173,011  150,944   11,768,958

 6   To re-elect Brian Phillips as a Director                                  11,474,597                     143,417  150,944   11,768,958

 7   To re-elect Jane Stewart as a Director                                    11,457,488                     160,526  150,944   11,768,958

 8   To re-appoint Johnston Carmichael LLP as Auditor                          11,366,653                     320,880  81,425    11,768,958

 9   To authorise the Directors to fix the remuneration of the Auditor         11,628,460                     59,073   81,425    11,768,958

 10  To authorise the Directors to allot new shares                            11,191,495                     470,185  107,278   11,768,958

 11  To authorise disapplication of pre-emption rights                         10,959,331                     591,651  217,976   11,768,958

 12  To authorise the Company to purchase its own shares                       10,812,508                     820,207  136,243   11,768,958

 13  To allow a general meeting to be called on not less than 14 days' notice  11,235,414                     452,119  81,425    11,768,958

 

A vote withheld is not a vote in law and any such votes have not been included
in the votes for or against the respective Resolutions. The voting figures
will be available to view at: www.mavencp.com/migvct5
(http://www.mavencp.com/migvct5) .

 

A copy of the Resolutions which require to be filed at Companies House have
also been submitted to the National Storage Mechanism and will shortly be
available for inspection at:

https://www.fca.org.uk/markets/primary-markets/regulatory-disclosures/national-storage-mechanism
(https://www.fca.org.uk/markets/primary-markets/regulatory-disclosures/national-storage-mechanism)

 

Issued on behalf of the Board

Maven Capital Partners UK LLP, Secretary

 

28 April 2026

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGIPMTTMTJTBJF



            Copyright 2019 Regulatory News Service, all rights reserved

Recent news on Maven Income and Growth VCT 5

See all news